Astrazeneca AB

Where the EU money came from

Funding by EU programme. Amounts are Astrazeneca AB's own share of each project, not the project's full budget.

Projects

160 EU-funded projects, newest first. Each links to the official record.

• DECODESPartner

  Deciphering the Splicing Code in Human Disease

  Horizon Europe · 2027–2030 · Project on CORDIS ↗

  €325ktheir share
• LUNG-GENEMEDAssociated partner

  A doctoral training programme for next-generation LUNG-targeted non-viral GENEtic MEDicines

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• AIMARIAAssociated partner

  Accelerating Innovation in Marine AI-powered Bioprospecting

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• MD4SBAssociated partner

  Molecular Dynamics for Structure-based Biology

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• EXIT-CVDPartner

  EXIT-CVD

  Horizon Europe · 2026–2031 · Project on CORDIS ↗
• HaloVerseAssociated partner

  Advancing Europe's Next Generations on the Path to Sustainability – Expanding the Universe of Enzymatic Halogenation Chemistry

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• ELEGANCEAssociated partner

  Machine learning for integrated multi-parametric enzyme and bioprocess design

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• ON-TRACTAssociated partner

  OligoNucleotide Technologies for Rapid Advancement of Cancer Therapies

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• NEXTMARINEPartner

  Novel enzymes from extreme marine environments as a source for value-added targets

  Horizon Europe · 2025–2029 · Project on CORDIS ↗

  €318ktheir share
• UNIFIEDPartner

  Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• LifeLUNGAssociated partner

  Improving Life expectancy of LUNG transplant recipients through innovative ex vivo perfusion gene therapy

  Horizon Europe · 2025–2029 · Project on CORDIS ↗
• LIGAND-AIAssociated partner

  Protein-ligand data generation at scale to support computational hit finding and optimization

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• BIOPHAMAssociated partner

  Bio and Pharmaceutical Materials Science

  Erasmus+ (ERASMUS+) · 2025–2031 · Project on the EU portal ↗
• LowDataMLPartner

  Low Data Machine Learning for Sustainable Chemical Sciences

  Horizon Europe · 2025–2029 · Project on CORDIS ↗

  €325ktheir share
• SciLifeLab PULSEAssociated partner

  SciLifeLab Programme for fUture Leaders in life SciencE

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• NAP4DIVEPartner

  Non-Animal Platform for Nanoparticle-Based Delivery across the blood-brain barrier Interface with Vehicle Evolution

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €871ktheir share
• READIPartner

  REpresentative Clinical Research - ADvancing Inclusivity in Europe

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• EFFECTPartner

  A European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across Tissues

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €294ktheir share
• GRANITEAssociated partner

  Integrated AI Diagnostics in Breast Cancer

  Horizon Europe · 2024–2026 · Project on CORDIS ↗
• Project-COMFORTPartner

  Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• MC4DDPartner

  Macrocycles for Drug Discovery

  Horizon Europe · 2024–2028 · Project on CORDIS ↗

  €294ktheir share
• MeCHaNiSMAssociated partner

  Mechanical Characterisation of Nucleic Acids using Single Molecule Methods

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• NATPRIMEPartner

  Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers

  Horizon Europe · 2024–2028 · Project on CORDIS ↗

  €294ktheir share
• ERDERAAssociated partner

  EUROPEAN RARE DISEASES RESEARCH ALLIANCE

  Horizon Europe · 2024–2031 · Project on CORDIS ↗
• TargetRNAPartner

  Targeting RNA with small molecules

  Horizon Europe · 2024–2028 · Project on CORDIS ↗

  €294ktheir share
• FluoNeeDAssociated partner

  Fluorinated Lipid Nanoparticles for Gene Delivery and Diagnostics

  Horizon Europe · 2024–2026 · Project on CORDIS ↗
• LIVERAIMPartner

  A Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy

  Horizon Europe · 2024–2030 · Project on CORDIS ↗
• MIRACLEAssociated partner

  Multilevel inflammatory regulation in cardiometabolic disease

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• ORGESTRAAssociated partner

  Organoid technologies for disease modeling, drug discovery and development for rare diseases

  Horizon Europe · 2024–2027 · Project on CORDIS ↗
• CURE HEARTandBRAINAssociated partner

  CURE HEARTandBRAIN postdoctoral COFUND programme by CNIC

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• CirculH2Partner

  Hydrogenases for Large Scale Deployment of H2 as a Circular Energy Carrier in Industrial Biotechnology Based on Enzymatic Catalysts

  Horizon Europe · 2024–2027 · Project on CORDIS ↗

  €230ktheir share
• iCARE4CVDPartner

  INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

  Horizon Europe · 2023–2028 · Project on CORDIS ↗
• SCALEAssociated partner

  Industry empowerment to Multiphase fluid dynamics simulations using Artificial intelligence and Statistical methods on modern hardware architectures at Scale

  Horizon Europe · 2023–2028 · Project on CORDIS ↗
• MMMAssociated partner

  Medicine Made to Measure.

  Horizon Europe · 2023–2027 · Project on CORDIS ↗
• IDProAssociated partner

  Intrinsically disordered proteins in health and disease: mechanisms, molecular context and opportunities for drug discovery

  Horizon Europe · 2023–2027 · Project on CORDIS ↗
• AiChemistPartner

  Explainable AI for Molecules - AiChemist

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €587ktheir share
• AiRPaDDPartner

  Advancing Reaction Platforms for Drug Discovery

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €245ktheir share
• ISOBIOTICSPartner

  Isotopic Labeling of Biotherapeutics

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €587ktheir share
• BiodeCCodiNNgAssociated partner

  Decoding novel reaction chemistries in biocatalysis – Training Europe’s next visionaries for a sustainable future

  Horizon Europe · 2023–2027 · Project on CORDIS ↗
• GreenDigiPharmaAssociated partner

  Green and digital continuous-flow pharmaceutical manufacturing

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

Showing the 80 most recent of 160 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Janssen Pharmaceutica NVBelgium · 51 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 48 shared projects
• Pfizer LimitedUnited Kingdom · 48 shared projects
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 42 shared projects
• Novartis Pharma AGSwitzerland · 41 shared projects
• Sanofi-Aventis Recherche & DeveloppementFrance · 38 shared projects
• Eli Lilly and Company LtdUnited Kingdom · 36 shared projects
• Boehringer Ingelheim InternationalgmbhGermany · 31 shared projects
• Bayer AktiengesellschaftGermany · 30 shared projects
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 28 shared projects
• Karolinska InstitutetSweden · 25 shared projects
• Merck Kommanditgesellschaft Auf AktienGermany · 25 shared projects
• Novo Nordisk A/SDenmark · 24 shared projects
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 22 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 21 shared projects
• Uppsala UniversitetSweden · 21 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• RNA
• RNA viruses
• absorption spectroscopy
• additive manufacturing
• adverse drug reactions
• alcohols
• alkali metals
• alzheimer
• amines
• antibiotic resistance
• antibiotics
• arteriosclerosis
• artificial intelligence